A Review of the Indications, Outcomes, and Postoperative Management After Total and Completion Pancreatectomy for Pancreatic Cancer: More Is Not Necessarily Better [0.03%]
胰腺癌患者的全胰和残留胰腺切除术的指征、结局及术后管理的回顾：更多并不总是更好
Kailey M Oppat,Frances J Bennett,Shishir K Maithel
Kailey M Oppat
With improvements in surgical technique and advances in pancreatic endocrine and exocrine replacement therapy, the indications for, and threshold to perform, total or completion pancreatectomy in the modern surgical era are ever evolving. T...
Surgery for Borderline Resectable Pancreatic Ductal Adenocarcinoma: Preoperative Planning, Technical Considerations, and Building a Program [0.03%]
接近无法切除的胰腺导管腺癌手术：术前计划、技术考量及构建项目
Justin Drake,Daniel A Anaya,Jason B Fleming et al.
Justin Drake et al.
Pancreaticoduodenectomy, first described in 1935, has subsequently been refined over decades into the operation performed today for tumors of the pancreatic head and periampullary region. For years following Whipple's first publication, tum...
Brittany C Fields,Ching-Wei D Tzeng
Brittany C Fields
Locally advanced pancreatic cancer (LAPC) represents a unique clinical scenario in which the tumor is considered localized but unresectable due to anatomic factors. Despite a consensus against upfront surgery, no standard approach to induct...
Samuel Keltner,Bailey Nelson,Jordan Kharofa
Samuel Keltner
Pancreatic adenocarcinoma remains a deadly disease with 5 year overall survival of 10% among all stages. Standard of care for resectable disease remains surgical resection and adjuvant systemic therapy, but paradigms for borderline resectab...
Jessica L McMullin,Andrea Gillis
Jessica L McMullin
Endocrine Surgery [0.03%]
内分泌外科
Ronald F Martin
Ronald F Martin
Adriana Ramirez,Fiemu Nwariaku,Tricia Moo-Young et al.
Adriana Ramirez et al.
While there has been great progress in the past few decades in the management of endocrine surgery disorders, with adoption of new technologies and approaches, standardization of practice patterns, and guideline recommendations, unequal imp...
C Corbin Frye,Taylor C Brown,John A Olson Jr
C Corbin Frye
Multiple endocrine neoplasia (MEN) syndromes are rare autosomal dominant diseases that are associated with a mixture of both endocrine and non-endocrine tumors. Traditionally, there are 2 types of MEN that have unique clinical associations:...
Surgical Management and Long-Term Evaluation of Pancreatic Neuroendocrine Tumors [0.03%]
胰腺神经内分泌肿瘤的手术治疗及长期评估
Shadin Ghabra,Bhavishya Ramamoorthy,Stephen G Andrews et al.
Shadin Ghabra et al.
Pancreatic neuroendocrine tumors (PNETs) arise from neuroendocrine cells and are a rare class of heterogenous tumors with increasing incidence. The diagnosis, staging, treatment, and prognosis of PNETs depend heavily on identifying the hist...
Joseph Tobias,Xavier M Keutgen
Joseph Tobias
Pancreatic neuroendocrine tumors originate from hormone-producing islet cells and have a propensity to metastasize to the liver once they reach 2 cm in size. Their diagnosis relies upon a combination of computed tomography, MRI, DOTATATE PE...